step 9 semaglutide Efficacy and safety of once-weekly 2·4 mg versus placebo in people with obesity and prediabetes (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trial Semaglutide dosage in units: the

Biochemical pharmacology , 79 (7), 1000-1006

Warnings and precautions: Tell your doctor or nurse: If you are aware of abnormal heart beats whilst receiving Hydroxocobalamin injections

Never change medications without professional medical guidance

Both diindolylmethane (DIM) and sulforaphane glucosinolate (SGS) from broccoli sprouts and other cruciferous vegetables act to support phase I and II of estrogen metabolism

The most common side effects, which can affect up to one in ten people, are headache, nausea, vomiting, diarrhoea, constipation, stomach pain, feeling weak or fatigued.

References to GLP-1 relate to general biological mechanisms discussed in published research and do not indicate pharmaceutical equivalence